English
Segment disclosures
Company overviewQuanome Technologies, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Chief Operating Decision Maker · External Customers · Crossborder Freight Solutions
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=lsh:ExternalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-12-31 | 8110140 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4181714 | USD | 20251119 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 6702063 | USD | 20260219 | Open filing evidence |
Chief Operating Decision Maker · External Customers · Pharmaceutical Distribution China
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=lsh:ExternalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=lsh:PharmaceuticalDistributionChinaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-03-31 | 5108387 | USD | 20260519 | Open filing evidence |
| 2024-07-01 – 2025-03-31 | 715362 | USD | 20260519 | Open filing evidence |
Chief Operating Decision Maker · External Customers · Pharmaceutical Distribution
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=lsh:ExternalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=lsh:PharmaceuticalDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-12-31 | 3780654 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1338015 | USD | 20251119 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 218086 | USD | 20260219 | Open filing evidence |
Chief Operating Decision Maker · Nonrelated Party · Crossborder Freight Solutions
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-06-30 | 13122145 | USD | 20251014 | Open filing evidence |
Chief Operating Decision Maker · Nonrelated Party · Pharmaceutical Distribution
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:PharmaceuticalDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-06-30 | 2762465 | USD | 20251014 | Open filing evidence |
Chief Operating Decision Maker · Related Party · Crossborder Freight Solutions
Title Of Individual · Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
srt:TitleOfIndividualAxis=lsh:ChiefOperatingDecisionMakerMember;us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:RelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-12-31 | 1221728 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 580160 | USD | 20251119 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 1905815 | USD | 20251014 | Open filing evidence |
| 2024-07-01 – 2024-12-31 | 756994 | USD | 20260219 | Open filing evidence |
Nonrelated Party · Crossborder Freight Solutions
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-03-31 | 9559567 | USD | 20250515 | Open filing evidence |
Nonrelated Party · Crossborder Freight Solutions US
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsUSMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-12-31 | 6702063 | USD | 20250214 | Open filing evidence |
Nonrelated Party · Pharmaceutical Distribution China
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:PharmaceuticalDistributionChinaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-12-31 | 218086 | USD | 20250214 | Open filing evidence |
Nonrelated Party · Pharmaceutical Distribution
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:NonrelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:PharmaceuticalDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-03-31 | 715362 | USD | 20250515 | Open filing evidence |
Related Party · Crossborder Freight Solutions
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:RelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2025-03-31 | 1205354 | USD | 20250515 | Open filing evidence |
Related Party · Crossborder Freight Solutions US
Related Party Transactions By Related Party · Statement Business Segments
Source dimensions
us-gaap:RelatedPartyTransactionsByRelatedPartyAxis=us-gaap:RelatedPartyMember;us-gaap:StatementBusinessSegmentsAxis=lsh:CrossborderFreightSolutionsUSMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-12-31 | 756994 | USD | 20250214 | Open filing evidence |